Illustration of a glowing microchip with multiple processors connected by illuminated circuit lines, representing advanced semiconductor and AI technology
Reading Time: < 1 minute
Sectors
 
-Zhai Jun, Special Envoy of the Chinese Government on the Middle East Issue, met with Irit Ben-Abba, Ambassador of Israel to China. The two sides exchanged views on the current tense situation in the Middle East.
 
-Zhou Liang, Member of the Party Committee and Vice Chairman of the National Administration of Financial Regulation, is suspected of serious violations of discipline and law. He is currently under disciplinary review and supervision investigation by the Central Commission for Discipline Inspection and the National Commission of Supervision.
 
Industry
 
-OpenClaw has received its largest update since its launch. However, the forced migration of its plugin ecosystem from the public npm registry to the official ClawHub triggered an instantaneous surge in traffic, causing system-wide errors in the new version.
 
-Damo Academy of Alibaba has launched its new flagship CPU product, the Xuantie C950, whose performance has reached the industry-leading level. Alibaba.com has officially rolled out its first enterprise-level AI agent, Accio Work, overseas. Building on the general capabilities of “OpenClaw”, Accio Work further focuses on vertical scenarios such as business operations and e-commerce management. Compared with “OpenClaw”, Accio Work supports instant use upon download without additional deployment, and is now available to users worldwide.
 
Mar 24 Block Trade Info
 
*Discount
 
– Oriental Ocean Sci-Tech (002086 CH) saw 2 block trades worth 51.87mn at 1.85yuan per share, 9.76pct discount from last closing.
 
*Premium
 
– Kangtai Biological Products (300601 CH) saw 11 block trades worth 77.66mn at 14.60yuan per share, 10.86pct premium from last closing.
 
– Ecobeauty (000010 CH) saw 1 block trades worth 71.61mn at 4.45yuan per share, 3.25pct premium from last closing.
 

For more insights, please visit Orient Futures Singapore’s research platform, 
Finoview.

Disclaimer

We, Orient Futures International (Singapore) Pte. Ltd. (“OFIS”) (UEN No. 201831776Z), hold a capital markets services licence (CMS100869) from the Monetary Authority of Singapore for dealing in capital market products such as futures/derivatives contracts, and spot foreign exchange contracts for the purposes of leveraged foreign exchange trading, and is an Exempt Financial Adviser. For more information about OFIS, please visit the MAS Financial Institutions Directory

All content, materials, information, data, statistics, features, research, documents or reports available on our website (including this article) which are financial in nature (the “Content”) are governed by our Terms of Use. By accessing, using or downloading any Content, you are deemed to have consented and agreed to the Terms of Use.

We distribute information/research (which may be prepared by us directly or produced by our foreign affiliated companies within the Orient Group of companies) pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. The information/research herein is prepared and distributed in Singapore and is intended for our clients who are Accredited Investors, Expert Investors or Institutional Investors only. If you are not an Accredited Investor, Expert Investor or Institutional Investor, you hereby acknowledge and agree that you are not the intended audience of all Content available on our website, and you undertake to immediately cease your access to any Content available on our website.

You agree to access and accept all Content available on our website on an “as-is” and “as available” basis. You agree that OFIS shall not have any responsibility or liability arising out of or in connection with, and you agree to waive the right to bring any claims or raise any complaints against OFIS in respect of any Content available on our website. OFIS shall also not be liable for any damage, loss or liability of any kind (whether actual, anticipated, consequential, special, economic or otherwise) caused as a result (direct or indirect) of the use of, or inability to access or use, the website, including but not limited to any damage, loss or liability suffered as a result of your reliance on the Content or our website.

OFIS does not make any representations, and hereby disclaim all warranties, express or implied, statutory or otherwise to the extent permitted by law, in respect of our website and all Content therein. To the fullest extent permissible, OFIS does not warrant and hereby disclaims any warranty as to the accuracy, correctness, completeness, reliability, timeliness, non-infringement, title, merchantability or fitness for any particular purpose of the Content.

All Content available on our website are general in nature and have been prepared without any consideration of your investment objectives, financial situations or needs. You should consider the appropriateness of any Content available on our website having regard to your personal circumstances before making any investment decisions. You should take into account your investment objectives and financial situation and seek advice from an independent financial advisor under a separate engagement if necessary.

Subscribe to our weekly newsletter to get the latest market news